Oncotarget
The cover for issue 87 of Oncotarget features Figure 1, "The survival rate of genetically engineered mice with pancreatic ductal adenocarcinoma treated with a weekly injection of nano-albumin bound paclitaxel (NAB-paclitaxel) alone (orange line, n = 4), NAB-paclitaxel 3 hours after CYT-6091 treatment (green line, n = 4), and vehicle control (blue line, n = 3)," by Libutti, et al.
MiRNAs prognostic for basal and BRCA1 breast cancer |
https://doi.org/10.18632/oncotarget.26297 Bhupinder Pal, and Robin L. Anderson |
35717-35718 |
PDF | How to cite | Order a Reprint |
A triple drug combination as a novel anti-glioma therapy? |
https://doi.org/10.18632/oncotarget.26279 Yiru Zhang, Georg Karpel-Massler, and Markus D. Siegelin |
35719-35720 |
PDF | How to cite | Order a Reprint |
Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD |
https://doi.org/10.18632/oncotarget.26291 Kidist Ashami, John F. DiPersio, and Jaebok Choi |
35721-35722 |
PDF | How to cite | Order a Reprint |
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure |
https://doi.org/10.18632/oncotarget.26267 Steven K. Libutti, Lawrence Tamarkin, and Naris Nilubol |
35723-35725 |
Abstract | PDF | HTML | How to cite | Press Release | Order a Reprint |
Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma |
https://doi.org/10.18632/oncotarget.26284 Steven Georges, Lidia Rodriguez Calleja, Camille Jacques, Melanie Lavaud, Brice Moukengue, Fernando Lecanda, Thibaut Quillard, Marta Tellez Gabriel, Pierre-François Cartron, Marc Baud’huin, François Lamoureux, Dominique Heymann, and Benjamin Ory |
35726-35741 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance |
https://doi.org/10.18632/oncotarget.26285 Yusuke Takahashi, Takashi Eguchi, Koji Kameda, Shaohua Lu, Raj G. Vaghjiani, Kay See Tan, William D. Travis, David R. Jones, and Prasad S. Adusumilli |
35742-35751 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease |
https://doi.org/10.18632/oncotarget.26293 Belal A. Al-Husein, Bara’ Dawah, Saleem Bani-Hani, Samir M. Al Bashir, Khaled M. Al-Sawalmeh, and Nehad M. Ayoub |
35752-35761 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
https://doi.org/10.18632/oncotarget.26299 Nuha Mahmoud, Mohamed E.M. Saeed, Yoshikazu Sugimoto, Sabine M. Klauck, Henry J. Greten, and Thomas Efferth |
35762-35779 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes |
https://doi.org/10.18632/oncotarget.23200 Bo Tu, Jingfeng Bi, Dan Wu, Peng Zhao, Lei Shi, Yangxin Xie, Xin Zhang, Zhe Xu, Suxia Liu, Xinhua Wang, Xiaoxi Li, Fusheng Wang, and Enqiang Qin |
35780-35789 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article |
https://doi.org/10.18632/oncotarget.26271 Victor I. Seledtsov, and Galina V. Seledtsova |
35790-35794 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures |
https://doi.org/10.18632/oncotarget.26339 Bassil Dekky, Michael Ruff, Dominique Bonnier, Vincent Legagneux, and Nathalie Théret |
35795-35795 |
Correction | PDF | How to cite |
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma |
https://doi.org/10.18632/oncotarget.26340 Gilles Pagès |
35796-35796 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC